Jia Wei Xiao Yao San: Herb-Drug Interactions
According to a survey from the National Health Insurance
Research Database (NHIRD), Jia-Wei-Xiao-Yao-San (JWXYS) is the most popular
Chinese medicine for cancer patients in Taiwan. 5-Fluorouracil (5-FU) is a
general anticancer drug for the chemotherapy. To investigate the herb-drug
interaction of JWXYS on pharmacokinetics of 5-FU, a microdialysis technique
coupled with a high-performance liquid chromatography system was used to
monitor 5-FU in rat blood and brain. Rats were divided into four parallel
groups, one of which was treated with 5-FU (100 mg/kg, i.v.) alone and the
remaining three groups were pretreated with a different dose of JWXYS (600,
1200, or 2400 mg/kg/day for 5 consecutive days) followed by a combination with
5-FU. This study demonstrates that 5-FU with JWXYS (600 mg/kg/day or
1200 mg/kg/day) has no significant effect on the pharmacokinetics of 5-FU in
the blood and brain. However, JWXYS (2400 mg/kg/day) coadministered with 5-FU
extends the elimination half-life and increases the volume of distribution of
5-FU in the blood. The elimination half-life of 5-FU in the brain for the
pretreatment group with 2400 mg/kg/day of JWXYS is significantly longer than
that for the group treated with 5-FU alone and also reduces the clearance. This
study provides practical dosage information for clinical practice and proves
the safety of 5-FU coadministered with JWXYS.
Chiang MH,
Chang LW,
Wang JW,
Lin LC,
Tsai TH.
Herb-drug pharmacokinetic
interaction of a traditional chinese medicine jia-wei-xiao-yao-san with
5-Fluorouracil in the blood and brain of rat using microdialysis. Evid Based
Complement Alternat Med. 2015;2015:729679.
No comments:
Post a Comment